RAND Europe, as part of the Cambridge Centre for Health Services Research, is conducting an independent evaluation of telephone triage in general practices, using a mixture of qualitative and quantitative data collection.
RAND Europe is leading a research area within the Addictions and Lifestyles in Contemporary Europe – Reframing Addictions Project, a 5-year EU project to help policymakers rethink approaches to the human and economic costs of addictions by weaving the work of over 150 scientists in 25 countries into an integrated evidence base.
RAND Europe has been asked to support the on-going Accelerated Access Review of innovative medicines and medical technologies through conducting a study to examine international examples of accelerating the use of drugs, devices and diagnostics.
The National Institutes of Health Research has commissioned RAND Europe to assess the impact of the Health Technology Assessment programme over the ten-year period from 2003 to 2013 and identify the benefits resulting from the research that the programme funded, focusing in particular on its impact on health policy, practice and patients.
In the current economic climate, there is an increasing need for researchers to demonstrate the benefits resulting from the money invested in research. Ways to do this for social care research are not well established, and RAND Europe has been asked to investigate options including bibliometrics, surveys and economic analysis as part of the wider Social Care Evidence in Practice (SCEiP) project led by the London School of Economics.
The Better Obstetrics in Rural Nigeria (BORN) Study examines the effectiveness of the MSS. A nested qualitative study led by RAND Europe evaluated nine primary care clinics that appeared to be having differing success in terms of recruitment/retention of midwives and uptake of services.
RAND Europe’s growing work in the field of mental health and wellbeing draws on expertise from across a range of disciplines and methodological backgrounds to bring an innovative perspective to our projects. In particular, our well-established reputation in healthcare research is complemented by extensive science policy expertise, particularly in the field of research evaluation.
The International AIDS Vaccine Initiative (IAVI) helps to bridge the gap between scientific and technological potential and the needs of low income populations in low and middle income countries. RAND Europe is evaluating its capacity-building activities — including training, advocacy and broader community engagement activities — in Uganda, Kenya and Rwanda.
RAND Europe continues to provide research support to Vitality’s Britain’s Healthiest Company. It was commissioned in partnership with the University of Cambridge to help run the competition, which gives awards to companies for the healthiest employees and work environment. RAND Europe’s role includes designing and running the surveys, analysing results, and providing customised reports to participating companies. The project’s central aims are to raise awareness and gain a better understanding of how companies can engage with the wellness of their employees.
Researchers are reviewing the evidence of effectiveness, cost effectiveness, and qualitative evidence on changing risk-related behaviours pertaining to antimicrobial use to inform the development of Department of Health/NICE guidelines aimed at delaying antimicrobial resistance.
The Department of Health’s strategy for improving care and creating greater wealth through innovation, known as ‘Innovation, Health and Wealth’ (IHW), has the potential to systematically change the way the NHS operates. RAND Europe is evaluating whether and how IHW actions are working as planned, and contributing to achieving the strategy's overarching aims.
The number of people with dementia worldwide is predicted to rise threefold by 2050. An analysis of the UK's dementia research landscape and workforce capacity will help to inform research funding and capacity building efforts to ensure proper treatment, prevention, care, and greater scientific understanding of this condition.
To inform short and long term strategic and policy initiatives, RAND Europe is part of an initiative that aims to create an evidence base on the current reality of atrial fibrillation-related stroke management in Europe—with a particular focus on anticoagulation—as well as how this is likely to change over the near and medium terms.
The i4i programme supports the development of innovative medical technologies and their translation into clinical practice. RAND Europe is evaluating i4i to identify its impacts and the factors influencing performance.
To support the coordination of mental health research, RAND Europe is mapping the research funding ‘ecosystem’. Researchers are exploring who the major funders are, what kinds of research they support, and how their strategies relate to one another.
As part of the pan-EU project EPIC-CVD, which aims to provide clinicians and policymakers with a range of evidence-based policy options for cost-effective, individualised risk assessment for cardiovascular disease, researchers are exploring options for the implementation of new cardiovascular risk assessment tools across Europe.
Researchers are evaluating a new model of liaison and diversion (L&D) schemes, which aim to improve early identification of a range of health vulnerabilities among people passing through the UK youth or adult criminal justice system.
To help the Department of Health to determine the value-added and feasibility of social impact bonds, researchers are exploring whether SIBs help achieve better health and social care outcomes, and what the costs and challenges are of using these funding mechanisms.
At a time of reduced public spending there is interest in funding public services on a 'payment by results' basis under which the government pays for services only if and when they achieve defined outcomes. The Department of Health has commissioned a consortium that includes RAND Europe to conduct an independent evaluation of eight drug and alcohol recovery PbR pilots. The research is assessing whether and how the new funding approach encourages the development of the market for provision of services in these areas and more effective recovery programmes.
The 2014 Healthy Company Index competition in South Africa is currently running. RAND Europe will provide research and analytical support to the competition that aims to identify South Africa’s Healthiest Company.
At the interface between primary care and specialist care, community hospitals have the potential to play a major role in the management of acute and non-acute conditions. RAND Europe is collaborating with the University of Bournemouth to understand how the NHS can advance community hospitals and services in England, learning from comparable hospital models in other countries.
RAND Europe is one of five partners in the Policy Innovation Research Unit (PIRU), which brings together leading health and social care expertise to improve evidence-based policy-making and its implementation across the National Health Service, social care and public health. The Department of Health has funded PIRU with the goal of strengthening early policy development by exploiting the best routine data and by subjecting initiatives to speedy, thorough evaluation.
To help frame the debate on future EU membership in the context of UK health research, RAND Europe is assessing the benefits and burdens of membership. This research, for the Department of Health, will not only focus on funding, but also look at other aspects such as research environment, network effects, and knowledge spillovers. The project will include a series of scenario-based workshops to explore future impact of EU funding.
The European Commission Communication on Combating HIV/AIDS brought together interested parties from across the European region to draw up a set of targets and measures to be implemented. RAND Europe and Van Dijk Management Consultants are evaluating the second Communication and accompanying action plan to assess its implementation and help the Commission formulate a new policy framework.